Knowledge Hub

Research Background & Research Ideas: Profectus BioSciences, Inc. - Product Pipeline Review - 2016

Press release   •   Jul 18, 2016 07:34 EDT

Global Markets Directs, Profectus BioSciences, Inc. - Product Pipeline Review - 2016, provides an overview of the Profectus BioSciences, Inc.s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Profectus BioSciences, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Download Sample copy of this Report @


- The report provides a snapshot of the pipeline therapeutic landscape of Profectus BioSciences, Inc.

- The report provides overview of Profectus BioSciences, Inc. including its businessdescription, key facts, and locations and subsidiaries

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report assesses Profectus BioSciences, Inc.s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report features Profectus BioSciences, Inc.s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Profectus BioSciences, Inc.s strategic position with total access to detailed information on its product pipeline

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Profectus BioSciences, Inc.

- Identify potential new clients or partners in the target demographic

- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Profectus BioSciences, Inc.s pipeline depth and focus of pipeline therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Follow us on LinkedIn:

Table of Content :

Table of Contents 2

List of Tables 5

List of Figures 5

Introduction 6

Global Markets Direct Report Coverage 6

Profectus BioSciences, Inc. Snapshot 7

Profectus BioSciences, Inc. Overview 7

Key Information 7

Key Facts 7

Profectus BioSciences, Inc. - Research and Development Overview 8

Key Therapeutic Areas 8

Profectus BioSciences, Inc. - Pipeline Review 11

Pipeline Products by Stage of Development 11

Pipeline Products - Monotherapy 12

Pipeline Products - Combination Treatment Modalities 13

Pipeline Products - Partnered Products 14

Partnered Products/Combination Treatment Modalities 15

Profectus BioSciences, Inc. - Pipeline Products Glance 16

Profectus BioSciences, Inc. - Clinical Stage Pipeline Products 16

Phase I Products/Combination Treatment Modalities 16

Profectus BioSciences, Inc. - Early Stage Pipeline Products 17

Preclinical Products/Combination Treatment Modalities 17

Discovery Products/Combination Treatment Modalities 18

Profectus BioSciences, Inc. - Drug Profiles 19

(Ebola + Marburg) (monovalent) vaccine 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

(Ebola + Marburg) (trivalent) vaccine 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

HIV [strain C1086] vaccine 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

HIV-1 vaccine 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

IHV-001 27

Product Description 27

Mechanism of Action 27 is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.